Medasense today announced a collaboration with the Department of Anesthesiology and Perioperative Medicine at Thomas Jefferson University. The collaboration will involve a clinical trial examining the use of Medasense’s Nociception Level Index (NOL) technology during spine surgery procedures at Jefferson’s academic medical center in Philadelphia.
The initiative is being conducted as part of the Israel-U.S. HealthTech Pilot Program, a joint initiative of the Israel Innovation Authority and Thomas Jefferson University. The program is designed to facilitate the evaluation of healthcare technologies within the U.S. health system.
Spine surgery represents a high-impact clinical area where variability between patients in analgesic management remains significant. By utilizing NOL technology, clinicians can personalize analgesic dosing based on a patient’s actual physiological requirements. Jefferson’s medical center performs approximately 3,000 spine surgeries annually. The collaboration is expected to generate important real-world insights while supporting the development of initial U.S. health economic evidence.
As the company expands its clinical evidence base in the U.S., it remains focused on setting a new standard for how pain is monitored and managed in operating rooms and critical care settings globally.
